Nifty Pharma Prediction for Tomorrow, 21 July 2026: Index Jumps 1.40 Percent to 26,003.15, Monday’s Best Sector
- July 20, 2026
- Posted by: Ankit Jaiswal
- Category: News
Nifty Pharma prediction for tomorrow 21 July 2026: index at 26,003.15, up 1.40 percent on Monday, best sectoral performer. Support 25,660. Resistance 26,125.
Nifty pharma prediction for tomorrow: Nifty Pharma closed at 26,003.15 on Monday, up 358.15 points or 1.40 percent, the day’s best-performing sectoral index as defensive rotation favoured pharma amid a sharp banking-earnings-driven selloff that dominated the broader session. This nifty pharma prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.
Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for tomorrow reflects a clean reversal of Friday’s rotation, with the sector fully recovering its earlier decline as HDFC Bank and Axis Bank’s Q1 earnings disappointments pushed investors toward defensives specifically.
Click Here – Get Free Investment Predictions
Market Recap Behind the Nifty pharma prediction for tomorrow
The index opened at 25,699.30, touched a high of 26,126.20 and a low of 25,657.60 before closing at 26,003.15, its strongest session in weeks. Ankit Jaiswal notes that pharma’s outperformance came even as Sensex fell 0.57 percent, a clear divergence confirming genuine sector rotation into defensives rather than broad-based buying.
Nifty pharma prediction for tomorrow: Trend and Key Levels
Trend: Bullish Above 25,660
| Level Type | Value |
|---|---|
| Support 1 | 25,660 |
| Support 2 | 25,470 |
| Resistance 1 | 26,125 |
| Resistance 2 | 26,250 |
Ankit Jaiswal flags 25,660 as the key support, with 26,125 as the near-term resistance, matching Monday’s high. A close above 26,250 would confirm the sector’s defensive rally has further room, while a break under 25,470 would suggest today’s rotation is reversing quickly.
Global Cues for Nifty Pharma Tomorrow
Brent crude topped 90 dollars a barrel for the first time this cycle on Monday, the ninth straight day of US airstrikes on Iran, before easing off those highs after Iran signalled it had received a mediation proposal. Domestically, Q1 FY27 earnings dominated the session: HDFC Bank and Axis Bank both fell around 5 percent on sequential margin compression, while ICICI Bank and Reliance Industries beat estimates. PSU banks surged on strong results, and the rupee weakened to around 96.40 per dollar. Pharma is largely insulated from these earnings-driven and currency cues, since the sector’s fortunes depend more on US generic pricing trends and domestic demand, which is exactly why it benefited from defensive rotation on Monday.
Key Triggers in the Nifty pharma prediction for tomorrow
These triggers dominate the outlook heading into Monday, 13 July 2026:
- Continued defensive rotation: If banking earnings concerns keep dominating, further rotation into defensives like pharma would likely continue.
- US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
- HDFC Bank fell 5.12 percent to Rs 777.60 on Monday after its Q1 FY27 results showed sequential margin compression, the worst move among Nifty 50 heavyweights alongside Axis Bank’s similar decline.
Talk to a SEBI Registered Investment Advisor Before Your Next Trade
Stocks to Watch in the Pharma Sector
Key pharma constituents worth tracking alongside the broader sector outlook.
Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.
Nifty Healthcare: The closely related healthcare index moved in a similarly strong fashion on Monday.
Risks to the Nifty pharma prediction for tomorrow
These factors can invalidate this outlook:
- Rotation reversal: If banking concerns ease, defensive sectors like pharma could see some profit booking.
- US regulatory setback: Any adverse FDA decision would be a clear sector-specific negative.
- Overextended single-day gain: After a strong 1.40 percent rally, some consolidation would not be unusual.
Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.
Conclusion
The Nifty Pharma prediction for tomorrow, 21 July 2026, is bullish above 25,660, after the sector posted its strongest session in weeks amid a clean defensive rotation on Monday. Ankit Jaiswal flags 25,660 as the key support in the Nifty Pharma prediction for tomorrow, with continued banking earnings developments the key variable for further rotation heading into Tuesday.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on the Nifty pharma prediction for tomorrow
What is the Nifty Pharma prediction for tomorrow, 21 July 2026?
Ans. The Nifty Pharma prediction for tomorrow, 21 July 2026, is bullish above 25,660. The index closed at 26,003.15 on Monday, up 1.40 percent, the day’s best-performing sector.
Which analyst gave the Nifty Pharma prediction for tomorrow?
Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for tomorrow, flagging 25,660 as the key support level.
Why did Nifty Pharma outperform on Monday?
Ans. Nifty Pharma rose 1.40 percent on Monday as classic defensive rotation favoured the sector, with investors moving into pharma’s relatively insulated profile while banking stocks crashed on HDFC Bank and Axis Bank’s disappointing Q1 results.
Will the Nifty Pharma prediction for tomorrow’s rally continue?
Ans. The Nifty Pharma prediction for tomorrow notes that continued banking earnings concerns would likely extend the current defensive rotation into pharma, while any stabilisation in broader sentiment could see some profit booking after Monday’s strong gain.
